Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quest Diagnostics Incorporated

http://www.questdiagnostics.com/

Latest From Quest Diagnostics Incorporated

Deal Watch: Dianthus Will Reach Public Markets Via Reverse Merger With Stalled-Out Magenta

After shutting down its trial for a leukemia conditioning agent due to a patient death, Magenta’s review of strategic alternatives concludes with a combination with complement inhibitor-focused Dianthus.

Deal Watch Business Strategies

Minute Insight: Quest Diagnostics To Acquire Haystack Oncology For $300M In Cash

Quest Diagnostics will buy liquid biopsy start-up Haystack Oncology for a total of $450m with plans to launch a cancer-detection test in 2024.

Minute Insights M & A

Finance Watch: New Funds Keep Venture Capital Flowing Into Biopharma

Private Company Edition: In the first week of April, Cure Ventures launched with a $350m fund, the Alzheimer’s Drug Discovery Fund received $200m for its venture philanthropy strategy and Canaan revealed $850m in new funds. Also, OnKure raised $53.7m and Phlow closed a $36m series B round. 

Financing Innovation

Finance Watch: Fundraising Shows Preference For Later-Stage Companies

Recent financings, including the $150m launch of Pathalys and a planned $100m IPO for Mineralys, illustrate the reality of biopharma funding in 2023 – that having near-term clinical trial milestones are key to fundraising this year. Companies with dwindling cash are conserving the funds they have left.

Financing Business Strategies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • Other Names / Subsidiaries
    • ADI Holding Company
    • Athena Diagnostics
    • Blueprint Genetics
    • Boyce and Bynum Pathology Laboratories
    • California Laboratory Associates (CLA)
    • Celera Group
    • Cleveland HeartLab Inc.
    • ExamOne
    • Hurley Medical Center
    • Pathway Diagnostics
    • PhenoPath
    • Shiel Medical Laboratory
    • Solstas Lab Partners
    • Summit Health
    • Superior Mobile Medics
    • Mid America Clinical Laboratories (MACL)
UsernamePublicRestriction

Register